COVID-19: Brazil prosecutors seek to stop purchases of India’s Covaxin

Vaccine made by Bharat Biotech yet to be backed up with Phase III clinical trial results

Last updated: February 27, 2021 | 18:25

1 MIN READ

File photo shows a medic administering Covaxin, an Indian government-backed experimental COVID-19 vaccine, to a health worker during its trials, at the Gujarat Medical Education & Research Society in Ahmedabad.

REUTERS

Also In This Package

COVID-19, cancer can't stop Mrs Santa Claus in Brazil

Photos: Brazil's revellers mourn for cancelled Carnival

Ballerina born without arms soars with her attitude

Brasilia: Brazilian prosecutors are seeking the immediate suspension of purchases of India’s COVID-19 vaccine Covaxin, according to a document seen by Reuters on Friday, one day after the Health Ministry signed a contract to purchase 20 million doses.

The vaccine made by private Indian company Bharat Biotech has yet to be backed up with Phase III clinical trial results, the prosecutors at the Federal Audit Court, known as the TCU, argued in seeking an injunction.

Get the latest news and updates straight to your inbox